Lion Biotechnologies (LBIO)

Lion Biotechnologies (LBIO) – FDA

Jun 5, 2017 08:02 AM Lion Biotechnologies (LBIO) Reports Updated Data from Ongoing LN-144 Phase 2 Clinical Trial at ASCO Meetings
Jun 1, 2017 04:30 PM Lion Biotechnologies (LBIO) Doses First Patient in Phase 2 Trial of LN-145 for Head and Neck
May 19, 2017 08:03 AM
Apr 19, 2017 08:08 AM
Nov 8, 2016 08:06 AM
Sep 15, 2016 09:51 AM
Apr 18, 2016 06:42 AM
Feb 1, 2016 08:04 AM
Jan 4, 2016 08:05 AM
Dec 21, 2015 12:08 PM
Dec 21, 2015 10:30 AM
Sep 17, 2015 07:23 AM
Sep 16, 2015 02:19 PM
Sep 14, 2015 08:09 AM
Jun 10, 2015 12:02 PM
Jun 2, 2015 09:09 AM
Apr 8, 2015 08:27 AM
Apr 1, 2015 12:29 PM
Mar 30, 2015 11:55 AM
Mar 30, 2015 06:28 AM
Jan 28, 2015 06:50 AM
Jan 26, 2015 08:27 AM
Sep 5, 2014 11:02 AM